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The prevalence of right to left shunt in chronic 
obstructive pulmonary disease patients with increased 
pulmonary hypertension     
Abstract 
Background: One of the important etiologies for cryptogenic stroke is paradoxical 
embolization secondary to Patent Foramen Ovale (PFO). Foramen ovale can secondarily 
reopen due to Pulmonary Arterial Hypertension (PAH) which is common among the older 
age. PAH is known as a frequent and life threatening complication of COPD. The aim of 
this study was to determine the prevalence of PFO between COPD patients with PAH and 
compare it with the ratio of PFO in non PAH COPD patients by Valsalva Maneuver (VM) 
following the TCD test. 
Methods: This study was performed on 55 patients with COPD exacerbation who were 
admitted to Rasul-Akram Hospital in Tehran, Iran. The patients with high PAH were 
considered as the case group and the others without PAH were the control group. All 
patients underwent Trascranial Doppler (TCD) to detect intracardiac right-to-left shunt 
(RLS) related by PFO. The data were collected and analyzed.   
Results: In the case group, among 45 patients 25 (55.5%) males and 20 (44.5%) females] 
with the mean age of 64.68±10.73 years, 31 (68.8%) subjects had PFO. In 10 control 
patients whose PAP were normal during TTE, we detected PFO in 2 (20%) patients during 
VM (p<0.001). There was a significant correlation with the number of microembolic 
signals (MES) and the increase in PAP (p=0.019). 
Conclusion: Right to left shunting was significantly more frequent in COPD patients with 
high PAP. High pulmonary pressure had a cardinal role in increasing the prevalence of 
RLS among these patients.  
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Stroke is the second cause of death in the world and a major contributor to long-
term functional impairment and disability (1,2). There are different subtypes of stroke and 
cryptogenic is one of the most common subtypes and consists of about 40 percent of all 
stroke cases (3). One of the important etiologies for cryptogenic stroke is paradoxical 
embolization secondary to Patent Foramen Ovale (PFO) and other atrial septal defects (4-
7). Foramen ovale is a physiological defect in interatrial septum that closes in most people 
right  after birth (8) but it can remain open in 10-30 percent of normal population that 
reduces with an increase in age (9-11). Also foramen ovale can secondarily reopen due to 
pathological conditions such as in Pulmonary Arterial Hypertension (PAH) which is more 
common among the older age (12). Pulmonary hypertension is known as a frequent and 
life threatening complication of COPD (13,14). One of the new and mini invasive methods 
for diagnosing PFO is using Trancranial Doppler (TCD) with valsalva maneuver (15,16).   
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In this method after the injection of contrast material in 
peripheral vessels and performance of valsalva maneuver by 
the patient, the number of high intensity transient signal 
(HITS) that are detected help make the diagnosis of PFO as 
well as its intensity (17). The emboli originate from systemic 
venous circulation and heart pass to systemic arterial 
circulation through atrial septal defect and block a part of 
cerebral circulation leading to ischemic stroke (18).  
The aim of this study was to determine the prevalence 
of PFO in COPD patients with PAH and comparing it with 
the ratio of PFO in non PAH COPD patients by Valsalva 
maneuver following the TCD test.    
Methods  
Patients: This prospective, analytical cross-sectional study 
was performed on 55 patients with COPD exacerbation who 
were admitted to Rasoul-e-Akram Hospital in Tehran, Iran. 
At first pulmonary function test was requested .Also 
Pulmonary arterial pressure (PAP) was determined using  
transthoracic echocardiography (TTE) with (Probe: 3.5-5 
MHZ transducer, Model: X-CD Megas, Italy) to rule out the 
cardiologic causes of possible right to left shunting (RLS). A 
four-chamber view was obtained to provide the best view of 
the fossa ovalis. During TTE, arterial oxygen saturation 
(SaO2) by finger pulse oximetry was recorded for all patients 
continuously. 
The patients with high PAP were considered as the 
case group and the others without PAH were the control 
group. It is noted that pulmonary artery hypertension (PAH) 
is defined as a mean pulmonary artery pressure greater than 
25 mmHg at rest or 30 mmHg with exercise. Forty five 
(82%) patients with PAH (case) and ten subjects (18%) with 
normal PAP (control) were diagnosed. The Iran University 
Institutional Review Board approved the study, and all the 
subjects were provided with the written informed consent to 
participate. 
Patent Foramen Ovale Detection: All patients underwent 
trascranial doppler (TCD) by injecting contrast agent during 
valsalva maneuver (VM) to detect intracardiac RLS. An 
emulsion of microbubbles as a sonographic contrast was 
prepared by agitating a mixture of 8 ml saline, 1 ml air and 
0.5 ml of the patient s blood as an emulsificant. This 
emulsion was then immediately injected via an 18-gauge 
cannula in an antecubital vein. Our protocol involved two 
cycle injections followed immediately by a standardized VM 
(patients were asked to hold their breath and then release it 
for 5 seconds followed by the injection). Each cycle lasted 
120 seconds to detect all the possible HITS passage, after a 
short rest, the patients had to undergo another set of injection 
followed by VM. Both middle cerebral arteries were 
insonated through the temporal windows using 2-MHz 
probes set at 50-60-mm depth. 
A right-to-left shunt was considered present if at least 
two microembolic signals (MES) passed in the two 60 
seconds time window after the injection while the first high 
intensity transient signals (HITS) occurred in the first 40 
seconds- contributing to the diagnostic criteria of PFO, 
which confirmed the existence of RLS which in our cases is 
sustained by PFO. TCD recordings were analyzed offline by 
2 independent trained observers.  
Statistical analysis: The data were analyzed using SPSS 
version 16 software for Windows (SPSS Inc, Chicago, IL, 
USA). The parameters such as frequency, mean, mode and 
standard deviation (S.D.) were reported. The analyses were 
performed using statistical tests. Kolmogronov Smirnov 
(K.S) test was performed to evaluate the normal distribution 
of the quantitative variables. To compare the differences of 
the values of continuous variables between the case and the 
control groups Independent T-test was used. For finding any 
predicting factor associated with occurrence of PFO we used 
Logistic Regression test. A p-values<0.05 was considered 
statistically significant. All reported p-values are two-tailed.   
Results 
In the case group of 45 patients 25 (55.5%) males and 
20 (44.5%) females with the mean age of 64.68 (SD=10.73) 
yr, 31(68.8%) patients have PFO. In our group of 10 control 
patients whose PAP was normal during TTE, we detected 
PFO in 2 (20%) patients during VM. This difference was 
statistically significant between the case and control groups 
(p=0.000). Other baseline and clinical characteristics of case 
and control groups are shown in Table 1. 
As shown in Table 2, in COPD patients with or without 
PFO, the differences were statistically significant for 
parameters such as tricuspid regurgitation (TR) (p=0.00), 
mitral regurgitation (p=0.01) and right ventricular end 
diastolic volume (REDV) (p=0.001). And was not significant 
for Pao2 (p=0.64), smoking (p=0.74), PAP (p=0.20) and 
FEV1/FVC (p=0.65). Since we used TCD as our PFO 
detection method, the TCD characteristics were of 
importance: 31 (68.9%) patients passed shunts during 
VM,27 (60%) patients were accounted as PFO, 8(8.9%) 
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patients passed delayed shunts, shower of emboli (shunts 
during rest and VM) was detected in 7 (15.6%) patients. 
When we used Logistic Regression analysis to determine the 
important factors associated with the occurrence of a PFO, 
we found that a cigarette load, Pao2, Sao2, FEV1 and PAPs 
did not show any significant association with the occurrence 
of PFO.   
Table1. Demographic Comparison between case (COPD 
with PAP more than 30 mmhg) and control group(COPD 
with PAP less than 30 mmhg)  










Hg 14.04±2.27 13.15±2.50 
PH 7.34±09 7.33±06 
Pao2 71±2.27 90.1±4.4 
FVC(%predicted) 61±20.7 63.13±25.21 
FEV1(%predicted) 52.64±24 70.12±14 
FEV1/FVC 68.17±16.9 82.4±18.1 
PAP(mmhg) 50.37±14.42 22.77±2.6 
RVED 3.5±0.9 2.8±54 
PFO  
  Yes 





Hg: hemoglobin; PaO2: O2 gradient in the blood; FVC: forced vital 
capacity; FEV1: forced expiratory volume during the first minute; 
RVED: right ventricular end diastolic volume; PAP: pulmonary 
artery pressure;  
Using the same method of analysis to determine the 
factors associated with occurrence of PFO showed that only 
the echocardiographic factors were in coordination with PFO 
occurrence. REDV (p=0.008) and TR (p=0.029) showed a 
meaningful association. And finally our regression in the 
field of neurosonology technique showed that there existed a 
significant correlation between the number of MES and the 
increase in PAP (p=0.019).  
But denies any linear correlation between the amount 
of increase in PAP and the likeliness of MES passage, 
meaning that the high MES passage was associated with 
higher PAP, but higher PAP did not necessary mean the 
definite passage of MES. 
Table 2.Comparison between the two groups in which 
PFO was/was not detected among our Case (raised-PAP) 
patients.  





Age(years)  65.2±12 63±6 0.60 
Gender 
   Male 







   Yes 








20.48±31.12 12.14±18.05 0.01 
hg 14.34±2.31 13.36±2.10 0.64 
PH 7.31±09 7.41±06 0.09 
PaO2 69.80±10 73.70±23 0.68 
Paco2 53.10±13.09 47.35±8.1 0.12 
O2sat 80.19±9.4 89.43±8.4 0.30 
FVC 60.01±27.03 64.18±17.46 0.04 
FEV1 50.71±26.11 53.52±19.18 0.08 
FEV1/FVC 70.95±16.01 66.03±18.77 0.65 
RVED 3.8±0.73 2.8±1.07 0.001 
PAP(mmhg) 53.12±16 42.50±8.9 0.23 
TR 
   Yes 







   <60mmhg 






PFO: Patent Foramen Ovale; PaO2: O2 gradient in the blood; 
O2sat: finger pulse oximetry arterial o2 saturation; FVC: forced 
vital capacity; FEV1: forced expiratory volume during the first 
minute; RVED: right ventricular end diastolic volume; PAP: 
pulmonary artery pressure.   
Discussion 
In this study, we used TCD to determine the prevalence 
of RLS in patients with COPD, who had pulmonary 
hypertension. We also evaluated the relationship between the 
amounts of increase in pulmonary hypertension and the 
presence of RLS. RLS was significantly more frequent in our 
45 consecutively studied patients than in a group of control 
subjects. The main characteristic that differed between our 
case and control subjects was the pulmonary pressure, 
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leading us to think that it played a cardinal role in increasing 
the prevalence of RLS among our patients. Here, we showed 
that the prevalence of RLS in our study patients was 
statically greater than previous similar studies (19) though 
none of the previous work strictly focused on pulmonary 
hypertension secondary to COPD. Our study also supports 
the previous findings that the prevalence of RLS during VM 
is significantly greater in COPD patients than in normal 
population. Several considerations should be made in order 
to explain our observations. The first relates to the technique 
used in this study to visualize RLS. The presence of RLS can 
be confirmed both invasively and none invasively. We used 
TCD as it is the non-invasive, simple, rapid, sensitive and 
specific and can be used at the bedside in neurology unit and 
can detect right-to-left shunts of both intracardiac and 
intrapulmonary origin. Naturally the gold standard method 
for detecting PFO is TEE as the shunts can be visualized and 
the source can be identified.  
Though in our study we worked with the PFO 
diagnostic criteria in TCD, we cannot be certain about the 
specific source of the shunts since TCD can confirm the 
existence of PFO only after it has been detected by TEE 
suggesting that TCD and TEE are complementary according 
to clinical situation and technological equipment. Our study 
did not focus on the shunt passage at rest, as we believe 
evaluations on that ground have been clear enough in 
pointing out that higher pulmonary pressure and longer 
duration of the disease are in definite correlation with RLS at 
rest as well as PFO re-occurrence. Since longer exposure to 
alveolar hypoventilation results in higher PAP which leads to 
permanent RLS through PFO. 
We used VM to detect RLS in our patients as it is also 
known to increase the sensitivity of TCD. A significant 
correlation between the amount of increase in PAP and 
occurrence of RLS would have led to the conclusion that our 
patients were ultimately going to reach the permanent 
shunting phase as their disease progressed. Such information 
could help start dealing with the consequences of permanent 
shunt earlier on. However, in our 45 patients with pulmonary 
hypertension secondary to COPD, no such correlation was 
found, suggesting that though pulmonary hypertension as a 
risk factor plays a role in causing significant RLS in our 
patients, it does not have a linear correlation with RLS. 
Consequently with the rise in pulmonary pressure one cannot 
necessarily expect the patients to progress from passing 
shunts with Valsalva maneuver to passing shunts at rest. 
Though the comparison between our case and control 
patients confirm that pulmonary hypertension is more likely 
in patients with RLS, the incoherence between the amount of 
increase in pulmonary pressure and the tendency for RLS 
point to other possible factors related to RLS.  
The only proven cause of stroke related to COPD is a 
transient rise of pressure inside the right sided cardiac 
chambers causing RLS of venous origin across either an 
incompletely sealed PFO or an intrapulmonary arterio-
venous connection. Given the fact that hypoxia leads to 
higher pulmonary pressure and that these patients tend to 
mimic the Valsalva maneuver with heavy coughing, they 
have higher risk of RLS. The higher number of RLS in 
COPD patients is reported here and the possible relationship 
between RLS via PFO and cryptogenic stroke that has 
been reported recently (20) leads to the speculation that such 
patients may benefit from anti-coagulation therapy. 
However, there was no significant history of CVA in our 
patients records and to our knowledge; there is no report in 
the literature of higher prevalence of CVA in COPD 
population. This leaves us with two possibilities: either our 
patients shunts were strictly pulmonary which cannot be the 
case since TCD findings were restricted to FPO, or the 
course of supportive treatment protected the patients from 
paradoxical embolism. We, therefore conclude that though 
further evaluation and follow up is mandatory, our data do 
not provide any evidence for anti-coagulation therapy as a 
prophylactic measure in COPD patients with pulmonary 
hypertension.   
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